Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Global Pharmaceutical Continuous Manufacturing Market 2024-2028
... continuous manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Global Pharmaceutical Vacuum Freeze Dryer Machine Market Growth 2023-2029
... demand in downstream market, the Pharmaceutical Vacuum Freeze Dryer Machine is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Marine Pharmaceuticals Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global RFID for Pharmaceutical Market Growth (Status and Outlook) 2023-2029
... in downstream market, the RFID for Pharmaceutical is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Merchant API Market (by Molecular Type, Segment, Type, Type of Synthesis, End-User, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)
... all activities related to the development and manufacture of active pharmaceutical ingredients (API) for both clinical trials and commercial products. Because of the expertise and equipment required to manufacture the compounds, there has been an ... Read More
-
Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)
... in the liver (steatosis), hepatocellular ballooning, and inflammation. Non-Alcoholic Steatohepatitis, also known as Silent Liver Disease, is a type of liver disorder caused by long-term alcohol abuse that primarily affects non-alcoholics or those who consume ... Read More
-
Global Lyophilization Equipment and Services Market 2024-2028
... on the lyophilization equipment and services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Supply Chain Planning and Network Design: Creating Supply Chain Oases for Expanding Food and Pharmaceutical Deserts
... deserts. Survey data from the life sciences industry indicates supply chain managers sense these shifts and are prioritizing investments to manage the supply chain response. Technology vendors will be called on to create solutions that ... Read More
-
Global Pharmaceutical Grade Glutathione Market Growth 2023-2029
... the Pharmaceutical Grade Glutathione is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research report highlights the growth potential of the global Pharmaceutical Grade ... Read More
-
Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 18.0 Billion by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2022-2028. Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair and nails. ... Read More
-
Telmisartan Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... by 2028, exhibiting a growth rate (CAGR) of 3.0% during 2022-2028. Telmisartan is a non-peptide angiotensin receptor blocker (ARB), which is used as a prescription drug for the treatment of hypertension and cardiovascular disorders. It ... Read More
-
Pharmerging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... by 2028, exhibiting a growth rate (CAGR) of 12.2% during 2022-2028. Pharmerging refers to a group of countries that hold low positioning in the pharmaceutical market but have a speedy growth. Some of the key ... Read More
-
Global Injectable Pharmaceuticals Labels Market Growth 2023-2029
... the Injectable Pharmaceuticals Labels is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research report highlights the growth potential of the global Injectable Pharmaceuticals ... Read More
-
Genitourinary Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 37.0 Billion by 2028, exhibiting a growth rate (CAGR) of 2.2% during 2022-2028. The genitourinary system includes kidneys, ureters, bladder, urethra, and genital organs, which play a vital role in reproduction and getting rid of ... Read More
-
Vaccine Contract Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... US$ 4.5 Billion by 2028, exhibiting a growth rate (CAGR) of 10.3% during 2022-2028. Vaccine contract manufacturing refers to the outsourcing of large-scale production of vaccines to contract manufacturing organizations (CMOs). These organizations offer numerous ... Read More
-
Pharmacovigilance Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2022-2028. Pharmacovigilance (PV) is the pharmacological science concerning the detection, assessment, understanding and prevention of unfavorable effects with pharmaceutical products. It plays a pivotal role ... Read More
-
Nanoparticle Contract Manufacturing (Focus on Lipid and Metal Nanoparticles) Market by Company Size (Very Small, Small, Mid-sized and Large), Type of Nanoparticle(s) Manufactured (Lipid and Metal Nanoparticles), Scale of Operation (Preclinical, Clinical and Commercial), Type of End User (Educational Institutions, Pharmaceutical Companies, Research Institutions, and Other End Users), and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2021-2035
... of End User (Educational Institutions, Pharmaceutical Companies, Research Institutions, and Other End Users), and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends ... Read More
-
Glucaric Acid Market - Global Glucaric Acid Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Type Coverage, By Application Coverage, By Geographic Coverage and By Company)
... market is poised for significant growth, with a projected market size of approximately US$2.6 billion by 2030, compared to US$1.3 billion recorded in 2022. The market is expected to grow at a solid CAGR of ... Read More
-
Pharmaceutical Isolator Market by Type (Open Isolator and Closed Isolator), by Pressure (Positive Pressure and Negative Pressure), by Configuration (Floor Standing, Mobile, and Table Top), by Application (Aseptic Isolators, Containment Isolators, Sampling/Weighing/Distribution Isolators, Fluid Dispensing Isolators, and Others), and by End User (Hospitals, Pharmaceutical & Biotechnology Companies, Research & Academic Laboratories, and Others) – Global Opportunity Analysis and Industry Forecast, 2024–2030
... Isolators, and Others), and by End User (Hospitals, Pharmaceutical & Biotechnology Companies, Research & Academic Laboratories, and Others) – Global Opportunity Analysis and Industry Forecast, 2024–2030 Meta Title: Pharmaceutical Isolator Market Size and Share | ... Read More
-
Modular Facilities in Pharmaceutical and Biotechnology Market (3rd Edition), 2023-2035
... Facilities. Modular Construction Involves Building Of Structures Using Prefabricated Modular Units, Off-site, Under Controlled Factory Setting; These Modular Units Are Later Assembled On Site. It Is Interesting To Note That Off-site Construction Can Eliminate 60%-90% ... Read More
-
Pharmaceutical Contract Manufacturing (3rd Edition), 2021-2030 Distribution by [A] business segment (API and FDF), [B] type of API (branded and generic), [C] type of FDF (oral solids, parenteral and others), [D] type of packaging form (blisters, bottles, injectables and others), [E] scale of operation (clinical and commercial), [F] end-users (large pharmaceutical companies, mid-sized pharmaceutical companies and small pharmaceutical companies) and [G] key geographical regions (North America, Europe, Asia-Pacific, Latin America, and Middle-East and North Africa): Industry Trends and Global Forecasts
... (blisters, bottles, injectables and others), [E] scale of operation (clinical and commercial), [F] end-users (large pharmaceutical companies, mid-sized pharmaceutical companies and small pharmaceutical companies) and [G] key geographical regions (North America, Europe, Asia-Pacific, Latin America, ... Read More
-
Pharmaceutical Glycerin Based Market Report: Trends, Forecast and Competitive Analysis to 2030
... plasticizer, solubilizer and emulsifier, solvent, coating, diluent and base, lubricant, thickener, and sweetener markets. The global pharmaceutical glycerin based market is expected to grow with a CAGR of 6.5% from 2024 to 2030. The major ... Read More
-
Global Anti-Counterfeit Packaging Market
... And By Geography – Covid-19 Impact Analysis, Post Covid Analysis, Opportunities, Trends And Forecast From 2023 to 2033 The global Anti-Counterfeit Packaging market was valued at $3.04 Billion in 2022 and is anticipated to grow ... Read More
-
DUPIXENT Drug Insight and Market Forecast − 2032
... the DUPIXENT for EoE in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this report along ... Read More
-
Vaccine Contract Manufacturing Market (3rd Edition), 2021-2030
... parameters, such as year of establishment, size of employee base, location of headquarters, number of vaccine manufacturing facilities, type of service(s) offered (cell / virus banking, analytical development / testing, formulation, process development, fill / ... Read More